Skip to content

Clinical trials

Completed Triple Negative Breast Neoplasms trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Triple Negative Breast Neoplasms Status: Completed Country / region: Belgium Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20081
20101
20121
20132
20141
20152
20164
20176
20184
20191
20201
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed27

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Hoffmann-La Roche3
AbbVie2
AstraZeneca2
Amgen1
Bayer1
Cantargia AB1
Celldex Therapeutics1
ETOP IBCSG Partners Foundation1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Triple Negative Breast Neoplasms27
Breast Neoplasms10
Carcinoma, Non-Small-Cell Lung9
Colorectal Neoplasms7
Neoplasms7
Melanoma5
Pancreatic Neoplasms4
Carcinoma, Hepatocellular3
Endometrial Neoplasms3
Head and Neck Neoplasms3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.